Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr., Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546–1558. doi:10.1126/science.1235122
   PubMed Web of Science ®Google Scholar
• Gotwals P, Cameron S, Cipolletta D, et al. Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer. 2017;17(5):286–301. doi:10.1038/nrc.2017.17
   PubMed Web of Science ®Google Scholar
• Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21(3):162–180. doi:10.1038/s41568-020-00320-2
   PubMed Web of Science ®Google Scholar
• Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211–218. doi:10.1016/j.tibs.2015.12.001
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Peiris-Pagés M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14(1):11–31. doi:10.1038/nrclinonc.2016.60
   PubMed Web of Science ®Google Scholar
• Warburg O. The metabolism of carcinoma cells. J Cancer Res. 1925;9(1):148–163. doi:10.1158/jcr.1925.148
   Google Scholar
• Heiden MGV, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi:10.1126/science.1160809
   PubMed Web of Science ®Google Scholar
• Estrella V, Chen T, Lloyd M, et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 2013;73(5):1524–1535. doi:10.1158/0008-5472.CAN-12-2796
   PubMed Web of Science ®Google Scholar
• Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17(4):351–359. doi:10.1038/ncb3124
   PubMed Web of Science ®Google Scholar
• Flaveny CA, Griffett K, El-Gendy Bel D, et al. Broad anti-tumor activity of a small molecule that selectively targets the Warburg effect and lipogenesis. Cancer Cell. 2015;28(1):42–56. doi:10.1016/j.ccell.2015.05.007
   PubMed Web of Science ®Google Scholar
• Marchiq I, Pouysségur J. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters. J Mol Med. 2016;94(2):155–171. doi:10.1007/s00109-015-1307-x
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G. Metabolic targets for cancer therapy. Nat Rev Drug Discov. 2013;12(11):829–846. doi:10.1038/nrd4145
   PubMed Web of Science ®Google Scholar
• Yang Z, Gao D, Cao Z, et al. Drug and gene co-delivery systems for cancer treatment. Biomater Sci. 2015;3(7):1035–1049. doi:10.1039/C4BM00369A
   PubMed Web of Science ®Google Scholar
• Kotov NA. Inorganic nanoparticles as protein mimics. Science. 2010;330(6001):188–189. doi:10.1126/science.1190094
   PubMed Web of Science ®Google Scholar
• Chang CH, Qiu J, O’Sullivan D, et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell. 2015;162(6):1229–1241. doi:10.1016/j.cell.2015.08.016
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, DeBerardinis RJ. Understanding the intersections between metabolism and cancer biology. Cell. 2017;168(4):657–669. doi:10.1016/j.cell.2016.12.039
   PubMed Web of Science ®Google Scholar
• Wickens JM, Alsaab HO, Kesharwani P, et al. Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. Drug Discov Today. 2017;22(4):665–680. doi:10.1016/j.drudis.2016.12.009
   PubMed Web of Science ®Google Scholar
• Oroojalian F, Beygi M, Baradaran B, Mokhtarzadeh A, Shahbazi M-A. Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy. Small. 2021;17(12):e2006484–e2006484. doi:10.1002/smll.202006484
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37. doi:10.1038/nrc.2016.108
   PubMed Web of Science ®Google Scholar
• Tay ZW, Chandrasekharan P, Chiu-Lam A, et al. Magnetic particle imaging-guided heating in vivo using gradient fields for arbitrary localization of magnetic hyperthermia therapy. ACS Nano. 2018;12(4):3699–3713. doi:10.1021/acsnano.8b00893
   PubMed Web of Science ®Google Scholar
• Huo D, Jiang X, Hu Y. Recent advances in nanostrategies capable of overcoming biological barriers for tumor management. Adv Mater. 2020;32:27.
   Web of Science ®Google Scholar
• Zhang L, Wang Z, Zhang Y, et al. Erythrocyte membrane cloaked metal-organic framework nanoparticle as biomimetic nanoreactor for starvation-activated colon cancer therapy. ACS Nano. 2018;12(10):10201–10211. doi:10.1021/acsnano.8b05200
   PubMed Web of Science ®Google Scholar
• Chang M, Hou Z, Wang M, Li C, Lin J. Recent advances in hyperthermia therapy-based synergistic immunotherapy. Adv Mater. 2020;33:2004788.
   Web of Science ®Google Scholar
• Chen D, Xu Q, Wang W, Shao J, Huang W, Dong X. Type I photosensitizers revitalizing photodynamic oncotherapy. Small. 2021;17:2006742.
   Web of Science ®Google Scholar
• Tang Z, Liu Y, He M, Bu W. Chemodynamic therapy: tumour microenvironment-mediated Fenton and Fenton-like reactions. Angew Chem Int Ed Engl. 2019;58(4):946–956. doi:10.1002/anie.201805664
   PubMed Web of Science ®Google Scholar
• Liang S, Deng X, Ma P, Cheng Z, Lin J. Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy. Adv Mater. 2020;32(47):2003214. doi:10.1002/adma.202003214
   Web of Science ®Google Scholar
• Liang J-L, Luo G-F, Chen W-H, Zhang X-Z. Recent advances in engineered materials for immunotherapy-involved combination cancer therapy. Adv Mater. 2021;33(31):2007630. doi:10.1002/adma.202007630
   Web of Science ®Google Scholar
• Zhang X, He C, Chen Y, et al. Cyclic reactions-mediated self-supply of H2O2 and O2 for cooperative chemodynamic/starvation cancer therapy. Biomaterials. 2021;275:120987. doi:10.1016/j.biomaterials.2021.120987
   PubMed Web of Science ®Google Scholar
• Jiang W, Luo X, Wei L, et al. The sustainability of energy conversion inhibition for tumor ferroptosis therapy and chemotherapy. Small. 2021;17(38):2102695. doi:10.1002/smll.202102695
   Web of Science ®Google Scholar
• Dai Y, Sun Z, Zhao H, et al. NIR-II fluorescence imaging guided tumor-specific NIR-II photothermal therapy enhanced by starvation mediated thermal sensitization strategy. Biomaterials. 2021;275:120935. doi:10.1016/j.biomaterials.2021.120935
   PubMed Web of Science ®Google Scholar
• Bankar SB, Bule MV, Singhal RS, Ananthanarayan L. Glucose oxidase–an overview. Biotechnol Adv. 2009;27(4):489–501. doi:10.1016/j.biotechadv.2009.04.003
   PubMed Web of Science ®Google Scholar
• Ooi AT, Gomperts BN. Molecular pathways: targeting cellular energy metabolism in cancer via inhibition of SLC2A1 and LDHA. Clin Cancer Res. 2015;21(11):2440–2444. doi:10.1158/1078-0432.CCR-14-1209
   PubMed Web of Science ®Google Scholar
• Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013;34(2–3):121–138. doi:10.1016/j.mam.2012.07.001
   PubMed Web of Science ®Google Scholar
• Wang J, Ye C, Chen C, et al. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8(10):16875–16886. doi:10.18632/oncotarget.15171
   PubMedGoogle Scholar
• Akins NS, Nielson TC, Le HV. Inhibition of glycolysis and glutaminolysis: an emerging drug discovery approach to combat cancer. Curr Top Med Chem. 2018;18(6):494–504. doi:10.2174/1568026618666180523111351
   PubMed Web of Science ®Google Scholar
• Ciscato F, Ferrone L, Masgras I, Laquatra C, Rasola A. Hexokinase 2 in cancer: a prima donna playing multiple characters. Int J Mol Sci. 2021;22(9):4716. doi:10.3390/ijms22094716
   PubMed Web of Science ®Google Scholar
• Yang B, Ding L, Chen Y, Shi J. Augmenting tumor-starvation therapy by cancer cell autophagy inhibition. Adv Sci. 2020;7(6):1902847. doi:10.1002/advs.201902847
   Web of Science ®Google Scholar
• Hanafy NA, Dini L, Citti C, Cannazza G, Leporatti S. Inhibition of glycolysis by using a micro/nano-lipid bromopyruvic chitosan carrier as a promising tool to improve treatment of hepatocellular carcinoma. Nanomaterials. 2018;8(1):34. doi:10.3390/nano8010034
   Web of Science ®Google Scholar
• Shen J, Kim HC, Su H, et al. Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics. Theranostics. 2014;4(5):487–497. doi:10.7150/thno.8263
   PubMed Web of Science ®Google Scholar
• Li YH, Li XF, Liu JT, et al. PKM2, a potential target for regulating cancer. Gene. 2018;668:48–53. doi:10.1016/j.gene.2018.05.038
   PubMed Web of Science ®Google Scholar
• Huang C, Zhu C, Chen J, et al. Nano-platelets as an oxygen regulator for augmenting starvation therapy against hypoxic tumor. Front Bioeng Biotechnol. 2020;8:571993. doi:10.3389/fbioe.2020.571993
   PubMed Web of Science ®Google Scholar
• Li J, Anraku Y, Kataoka K. Self-boosting catalytic nanoreactors integrated with triggerable crosslinking membrane networks for initiation of immunogenic cell death by pyroptosis. Angew Chem Int Ed Engl. 2020;59(32):13526–13530. doi:10.1002/anie.202004180
   PubMed Web of Science ®Google Scholar
• Dinda S, Sarkar S, Das PK. Glucose oxidase mediated targeted cancer-starving therapy by biotinylated self-assembled vesicles. Chem Commun. 2018;54(71):9929–9932. doi:10.1039/C8CC03599G
   PubMed Web of Science ®Google Scholar
• Zeng Y, Zhou H, Ding J, Zhou W. Cell membrane inspired nano-shell enabling long-acting Glucose Oxidase for Melanoma starvation therapy via microneedles-based percutaneous delivery. Theranostics. 2021;11(17):8270–8282. doi:10.7150/thno.60758
   PubMed Web of Science ®Google Scholar
• Fu LH, Qi C, Hu YR, Lin J, Huang P. Glucose oxidase-instructed multimodal synergistic cancer therapy. Adv Mater. 2019;31(21):e1808325. doi:10.1002/adma.201808325
   PubMed Web of Science ®Google Scholar
• Palikaras K, Lionaki E, Tavernarakis N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol. 2018;20(9):1013–1022. doi:10.1038/s41556-018-0176-2
   PubMed Web of Science ®Google Scholar
• Wang X, Li Y, Deng X, et al. Colloidally stabilized DSPE-PEG-glucose/calcium phosphate hybrid nanocomposites for enhanced photodynamic cancer therapy via complementary mitochondrial Ca(2+) overload and autophagy inhibition. ACS Appl Mater Interfaces. 2021;13(33):39112–39125. doi:10.1021/acsami.1c11583
   PubMed Web of Science ®Google Scholar
• Jing M, Li Y, Wang M, et al. Photoresponsive PAMAM-assembled nanocarrier loaded with autophagy inhibitor for synergistic cancer therapy. Small. 2021;17(38):e2102295–e2102295. doi:10.1002/smll.202102295
   PubMed Web of Science ®Google Scholar
• Wu F, Liu Y, Cheng H, et al. Enhanced cancer starvation therapy based on glucose oxidase/3-methyladenine-loaded dendritic mesoporous organosilicon nanoparticles. Biomolecules. 2021;11(9):1363. doi:10.3390/biom11091363
   PubMed Web of Science ®Google Scholar
• Ralser M, Wamelink MM, Struys EA, et al. A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth. Proc Natl Acad Sci U S A. 2008;105(46):17807–17811. doi:10.1073/pnas.0803090105
   PubMed Web of Science ®Google Scholar
• Chan L, Chen X, Gao P, et al. Coordination-driven enhancement of radiosensitization by black phosphorus via regulating tumor metabolism. ACS Nano. 2021;15(2):3047–3060. doi:10.1021/acsnano.0c09454
   PubMed Web of Science ®Google Scholar
• Zhongqi F, Xiaodong S, Yuguo C, Guoyue L. Can combined therapy benefit immune checkpoint blockade response in hepatocellular carcinoma? Anticancer Agents Med Chem. 2019;19(2):222–228. doi:10.2174/1871520618666181114112431
   PubMed Web of Science ®Google Scholar
• Wei G., Wang Y, Yang G, Wang Y, Ju R. Recent progress in nanomedicine for enhanced cancer chemotherapy. Theranostics. 2021; 11(13):6370-6392.
   Web of Science ®Google Scholar
• Pinedo HM, Giaccone G. Chemotherapy. Lancet 1997;349(Suppl 2):Sii7–Sii9. doi:10.1016/S0140-6736(97)90012-X
   PubMed Web of Science ®Google Scholar
• Pauwels EK, Erba P, Mariani G, Gomes CM. Multidrug resistance in cancer: its mechanism and its modulation. Drug News Perspect. 2007;20(6):371–377. doi:10.1358/dnp.2007.20.6.1141496
   PubMedGoogle Scholar
• Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52–79. doi:10.1016/j.ejpb.2015.03.018
   PubMed Web of Science ®Google Scholar
• Lee C, Raffaghello L, Brandhorst S, et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med. 2012;4(124):124ra127–124ra127. doi:10.1126/scitranslmed.3003293
   Web of Science ®Google Scholar
• Raffaghello L, Lee C, Safdie FM, et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Nat Acad Sci. 2008;105(24):8215–8220. doi:10.1073/pnas.0708100105
   PubMed Web of Science ®Google Scholar
• Nencioni A, Caffa I, Cortellino S, Longo VD. Fasting and cancer: molecular mechanisms and clinical application. Nat Rev Cancer. 2018;18(11):707–719. doi:10.1038/s41568-018-0061-0
   PubMed Web of Science ®Google Scholar
• Lu R, Zhou L, Liu Q, et al. Skillfully collaborating chemosynthesis with GOx-enabled tumor survival microenvironment deteriorating strategy for amplified chemotherapy and enhanced tumor ablation. Biomater Sci. 2021;9(5):1855–1871. doi:10.1039/D0BM01950J
   PubMed Web of Science ®Google Scholar
• Fu LH, Wan Y, Qi C, et al. Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy. Adv Mater. 2021;33(7):e2006892. doi:10.1002/adma.202006892
   PubMed Web of Science ®Google Scholar
• Fu LH, Hu YR, Qi C, et al. Biodegradable manganese-doped calcium phosphate nanotheranostics for traceable cascade reaction-enhanced anti-tumor therapy. ACS Nano. 2019;13(12):13985–13994. doi:10.1021/acsnano.9b05836
   PubMed Web of Science ®Google Scholar
• Yang C, Gao M, Zhao H, et al. A dual-functional biomimetic-mineralized nanoplatform for glucose detection and therapy with cancer cells in vitro. J Mater Chem B. 2021;9(18):3885–3891. doi:10.1039/D1TB00324K
   PubMed Web of Science ®Google Scholar
• Yang B, Chen Y, Shi J. Tumor-specific chemotherapy by nanomedicine-enabled differential stress sensitization. Angew Chem Int Ed Engl. 2020;59(24):9693–9701. doi:10.1002/anie.202002306
   PubMed Web of Science ®Google Scholar
• Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13(10):714–726. doi:10.1038/nrc3599
   PubMed Web of Science ®Google Scholar
• Chen Y, Yao Y, Zhou X, et al. Cascade-reaction-based nanodrug for combined chemo/starvation/chemodynamic therapy against multidrug-resistant tumors. ACS Appl Mater Interfaces. 2019;11(49):46112–46123. doi:10.1021/acsami.9b15848
   PubMed Web of Science ®Google Scholar
• Tang Y, Ji Y, Yi C, et al. Self-accelerating H(2)O(2)-responsive plasmonic nanovesicles for synergistic chemo/starving therapy of tumors. Theranostics. 2020;10(19):8691–8704. doi:10.7150/thno.45392
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhao Y, Bejjanki NK, et al. Nanoclustered cascaded enzymes for targeted tumor starvation and deoxygenation-activated chemotherapy without systemic toxicity. ACS Nano. 2019;13(8):8890–8902. doi:10.1021/acsnano.9b02466
   PubMed Web of Science ®Google Scholar
• Shan L, Fan W, Wang W, et al. Organosilica-based hollow mesoporous bilirubin nanoparticles for antioxidation-activated self-protection and tumor-specific deoxygenation-driven synergistic therapy. ACS Nano. 2019;13(8):8903–8916. doi:10.1021/acsnano.9b02477
   PubMed Web of Science ®Google Scholar
• Li J, Wei Z, Lin X, et al. Programmable therapeutic nanodevices with circular amplification of H(2) O(2) in the tumor microenvironment for synergistic cancer therapy. Adv Healthc Mater. 2019;8(10):e1801627. doi:10.1002/adhm.201801627
   PubMed Web of Science ®Google Scholar
• Zhang R, Feng L, Dong Z, et al. Glucose & oxygen exhausting liposomes for combined cancer starvation and hypoxia-activated therapy. Biomaterials. 2018;162:123–131. doi:10.1016/j.biomaterials.2018.02.004
   PubMed Web of Science ®Google Scholar
• Ren C, Liu H, Lv F, et al. Prodrug-based nanoreactors with tumor-specific in situ activation for multisynergistic cancer therapy. ACS Appl Mater Interfaces. 2020;12(31):34667–34677. doi:10.1021/acsami.0c09489
   PubMed Web of Science ®Google Scholar
• Cheng H, Jiang XY, Zheng RR, et al. A biomimetic cascade nanoreactor for tumor targeted starvation therapy-amplified chemotherapy. Biomaterials. 2019;195:75–85. doi:10.1016/j.biomaterials.2019.01.003
   PubMed Web of Science ®Google Scholar
• Liu X, Liu J, Meng C, et al. Pillar[6]arene-based supramolecular nanocatalysts for synergistically enhanced chemodynamic therapy by the intracellular cascade reaction. ACS Appl Mater Interfaces. 2021;13(45):53574–53585. doi:10.1021/acsami.1c15203
   PubMed Web of Science ®Google Scholar
• Sanmamed MF, Chen L. A paradigm shift in cancer immunotherapy: from enhancement to normalization. Cell. 2018;175(2):313–326. doi:10.1016/j.cell.2018.09.035
   PubMed Web of Science ®Google Scholar
• Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020;70(2):86–104. doi:10.3322/caac.21596
   PubMed Web of Science ®Google Scholar
• Thompson JA. New NCCN guidelines: recognition and management of immunotherapy-related toxicity. J Natl Compr Canc Netw. 2018;16(5s):594–596. doi:10.6004/jnccn.2018.0047
   PubMed Web of Science ®Google Scholar
• Neelapu SS, Tummala S, Kebriaei P, et al. Chimeric antigen receptor T-cell therapy - assessment and management of toxicities. Nat Rev Clin Oncol. 2018;15(1):47–62. doi:10.1038/nrclinonc.2017.148
   PubMed Web of Science ®Google Scholar
• Gibney GT, Weiner LM, Atkins MB. Predictive biomarkers for checkpoint inhibitor-based immunotherapy. Lancet Oncol. 2016;17(12):e542–e551. doi:10.1016/S1470-2045(16)30406-5
   PubMed Web of Science ®Google Scholar
• Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30(1):36–50. doi:10.1016/j.cmet.2019.06.001
   PubMed Web of Science ®Google Scholar
• DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369–382. doi:10.1038/s41577-019-0127-6
   PubMed Web of Science ®Google Scholar
• Chen L, Zhou L, Wang C, et al. Tumor-targeted drug and CpG delivery system for phototherapy and docetaxel-enhanced immunotherapy with polarization toward M1-type macrophages on triple negative breast cancers. Adv Mater. 2019;31(52):e1904997. doi:10.1002/adma.201904997
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang Y, Shi J, Wang L. A multimodal strategy of Fe(3)O(4)@ZIF-8/GOx@MnO(2) hybrid nanozyme via TME modulation for tumor therapy. Nanoscale. 2021;13(39):16571–16588. doi:10.1039/D1NR04196G
   PubMed Web of Science ®Google Scholar
• Shao Y, Wang Z, Hao Y, et al. Cascade catalytic nanoplatform based on “butterfly effect” for enhanced immunotherapy. Adv Healthc Mater. 2021;10(8):e2002171. doi:10.1002/adhm.202002171
   PubMed Web of Science ®Google Scholar
• Wang M, Chang M, Li C, et al. Tumor-microenvironment-activated reactive oxygen species amplifier for enzymatic cascade cancer starvation/chemodynamic /immunotherapy. Adv Mater. 2021;34(4):e2106010. doi:10.1002/adma.202106010
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2017;17(2):97–111. doi:10.1038/nri.2016.107
   PubMed Web of Science ®Google Scholar
• Garg AD, Agostinis P. Cell death and immunity in cancer: from danger signals to mimicry of pathogen defense responses. Immunol Rev. 2017;280(1):126–148. doi:10.1111/imr.12574
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013;31(1):51–72. doi:10.1146/annurev-immunol-032712-100008
   PubMed Web of Science ®Google Scholar
• Sun K, Hu J, Meng X, et al. Reinforcing the induction of immunogenic cell death via artificial engineered cascade bioreactor-enhanced chemo-immunotherapy for optimizing cancer immunotherapy. Small. 2021;17(37):e2101897–e2101897. doi:10.1002/smll.202101897
   PubMed Web of Science ®Google Scholar
• Yang B, Chen Y, Shi J. Reactive oxygen species (ROS)-based nanomedicine. Chem Rev. 2019;119(8):4881–4985. doi:10.1021/acs.chemrev.8b00626
   PubMed Web of Science ®Google Scholar
• Horsman MR, Mortensen LS, Petersen JB, Busk M, Overgaard J. Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol. 2012;9(12):674–687. doi:10.1038/nrclinonc.2012.171
   PubMed Web of Science ®Google Scholar
• Wang Z, Gong X, Li J, et al. Oxygen-delivering polyfluorocarbon nanovehicles improve tumor oxygenation and potentiate photodynamic-mediated antitumor immunity. ACS Nano. 2021;15:5405–5419.
   PubMed Web of Science ®Google Scholar
• Yang C, Liu Y, Su S, Gao N, Jing J, Zhang X. A multifunctional oxygen-producing MnO(2)-based nanoplatform for tumor microenvironment-activated imaging and combination therapy in vitro. J Mater Chem B. 2020;8(43):9943–9950. doi:10.1039/D0TB00529K
   PubMed Web of Science ®Google Scholar
• Liu P, Zhou Y, Shi X, et al. A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances. J Nanobiotechnol. 2021;19(1):149. doi:10.1186/s12951-021-00893-6
   PubMed Web of Science ®Google Scholar
• Pan W, Ge Y, Yu Z, et al. A cancer cell membrane-encapsulated MnO(2) nanoreactor for combined photodynamic-starvation therapy. Chem Commun. 2019;55(35):5115–5118. doi:10.1039/C9CC01386E
   PubMed Web of Science ®Google Scholar
• Yang X, Yang Y, Gao F, Wei JJ, Qian CG, Sun MJ. Biomimetic hybrid nanozymes with self-supplied H(+) and accelerated O(2) generation for enhanced starvation and photodynamic therapy against hypoxic tumors. Nano Lett. 2019;19(7):4334–4342. doi:10.1021/acs.nanolett.9b00934
   PubMed Web of Science ®Google Scholar
• Zhou Y, Niu B, Zhao Y, et al. Multifunctional nanoreactors-integrated microneedles for cascade reaction-enhanced cancer therapy. J Control Release. 2021;339:335–349. doi:10.1016/j.jconrel.2021.09.041
   PubMed Web of Science ®Google Scholar
• Wan X, Zhang H, Pan W, Li N, Tang B. An enzyme nanopocket based on covalent organic frameworks for long-term starvation therapy and enhanced photodynamic therapy of cancer. Chem Commun. 2021;57(44):5402–5405. doi:10.1039/D0CC07544B
   PubMed Web of Science ®Google Scholar
• Li SY, Cheng H, Xie BR, et al. Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy. ACS Nano. 2017;11(7):7006–7018. doi:10.1021/acsnano.7b02533
   PubMed Web of Science ®Google Scholar
• Liu S, Yan T, Sun J, et al. Biomimetic cascade polymer nanoreactors for starvation and photodynamic cancer therapy. Molecules. 2021;26(18):5609.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang Z, He W, Ren J, Wong CY. One-pot synthesis of a self-reinforcing cascade bioreactor for combined photodynamic/chemodynamic/starvation therapy. J Colloid Interface Sci. 2021;599:543–555. doi:10.1016/j.jcis.2021.03.173
   PubMed Web of Science ®Google Scholar
• Zhou Z, Song J, Nie L, Chen X. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev. 2016;45(23):6597–6626. doi:10.1039/c6cs00271d
   PubMed Web of Science ®Google Scholar
• Yu Z, Zhou P, Pan W, Li N, Tang B. A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis. Nat Commun. 2018;9(1):5044. doi:10.1038/s41467-018-07197-8
   PubMed Web of Science ®Google Scholar
• Yin SY, Liu W, Yang J, Li J. Synergistically enhanced multienzyme catalytic nanoconjugates for efficient cancer therapy. J Mater Chem B. 2021;9(29):5877–5886. doi:10.1039/D1TB00821H
   PubMed Web of Science ®Google Scholar
• Wang H, Wang Z, Tu Y, et al. Homotypic targeting upconversion nano-reactor for cascade cancer starvation and deep-tissue phototherapy. Biomaterials. 2020;235:119765. doi:10.1016/j.biomaterials.2020.119765
   PubMed Web of Science ®Google Scholar
• Lin LS, Song J, Song L, et al. Simultaneous Fenton-like ion delivery and glutathione depletion by MnO(2) -based nanoagent to enhance chemodynamic therapy. Angew Chem Int Ed Engl. 2018;57(18):4902–4906. doi:10.1002/smll.202001518
   PubMed Web of Science ®Google Scholar
• Augustine R, Kalva N, Kim HA, Zhang Y, Kim I. pH-responsive polypeptide-based smart nano-carriers for theranostic applications. Molecules. 2019;24(16):2961. doi:10.3390/molecules24162961
   PubMed Web of Science ®Google Scholar
• Zhang H, Lu F, Pan W, et al. A dual-catalytic nanoreactor for synergistic chemodynamic-starvation therapy toward tumor metastasis suppression. Biomater Sci. 2021;9(10):3814–3820. doi:10.1039/D1BM00240F
   PubMed Web of Science ®Google Scholar
• Wan X, Song L, Pan W, Zhong H, Li N, Tang B. Tumor-targeted cascade nanoreactor based on metal-organic frameworks for synergistic ferroptosis-starvation anticancer therapy. ACS Nano. 2020;14(9):11017–11028. doi:10.1021/acsnano.9b07789
   PubMed Web of Science ®Google Scholar
• Zhang L, Wan SS, Li CX, Xu L, Cheng H, Zhang XZ. An adenosine triphosphate-responsive autocatalytic Fenton nanoparticle for tumor ablation with self-supplied H(2)O(2) and acceleration of Fe(III)/Fe(II) conversion. Nano Lett. 2018;18(12):7609–7618. doi:10.1021/acs.nanolett.8b03178
   PubMed Web of Science ®Google Scholar
• Huo M, Wang L, Chen Y, Shi J. Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nat Commun. 2017;8(1):357. doi:10.1038/s41467-017-00424-8
   PubMed Web of Science ®Google Scholar
• Yuan P, Dou G, Liu T, et al. On-demand manipulation of tumorigenic microenvironments by nano-modulator for synergistic tumor therapy. Biomaterials. 2021;275:120956. doi:10.1016/j.biomaterials.2021.120956
   PubMed Web of Science ®Google Scholar
• Singh P, Youden B, Yang Y, et al. Synergistic multimodal cancer therapy using glucose Oxidase@CuS nanocomposites. ACS Appl Mater Interfaces. 2021;13(35):41464–41472. doi:10.1021/acsami.1c12235
   PubMed Web of Science ®Google Scholar
• Ying W, Zhang Y, Gao W, et al. Hollow magnetic nanocatalysts drive starvation-chemodynamic-hyperthermia synergistic therapy for tumor. ACS Nano. 2020;14(8):9662–9674. doi:10.1021/acsnano.0c00910
   PubMed Web of Science ®Google Scholar
• Yang C, Younis MR, Zhang J, Qu J, Lin J, Huang P. Programmable NIR-II photothermal-enhanced starvation-primed chemodynamic therapy using glucose oxidase-functionalized ancient pigment nanosheets. Small. 2020;16(25):e2001518.
   PubMed Web of Science ®Google Scholar
• Hu C, Wang J, Liu S, et al. Urchin-shaped metal organic/hydrogen-bonded framework nanocomposite as a multifunctional nanoreactor for catalysis-enhanced synergetic therapy. ACS Appl Mater Interfaces. 2021;13(4):4825–4834. doi:10.1021/acsami.0c19584
   PubMed Web of Science ®Google Scholar
• Zhu P, Luo W, Qian J, et al. GSH/ROS dual-responsive supramolecular nanoparticles based on Pillar[6]arene and betulinic acid prodrug for chemo-chemodynamic combination therapy. Molecules. 2021;26(19):5900. doi:10.3390/molecules26195900
   PubMed Web of Science ®Google Scholar
• Peng H, Qin YT, Feng YS, He XW, Li WY, Zhang YK. Phosphate-degradable nanoparticles based on metal-organic frameworks for chemo-starvation-chemodynamic synergistic antitumor therapy. ACS Appl Mater Interfaces. 2021;13(31):37713–37723. doi:10.1021/acsami.1c10816
   PubMed Web of Science ®Google Scholar
• Guo Y, Jia HR, Zhang X, et al. A glucose/oxygen-exhausting nanoreactor for starvation- and hypoxia-activated sustainable and cascade chemo-chemodynamic therapy. Small. 2020;16(31):e2000897. doi:10.1002/smll.202000897
   PubMed Web of Science ®Google Scholar
• Di Ianni T, Bose RJC, Sukumar UK, et al. Ultrasound/microbubble-mediated targeted delivery of anticancer microRNA-loaded nanoparticles to deep tissues in pigs. J Control Release. 2019;309:1–10. doi:10.1016/j.jconrel.2019.07.024
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhang L, Ran H, et al. A mitochondria-targeted anticancer nanoplatform with deep penetration for enhanced synergistic sonodynamic and starvation therapy. Biomater Sci. 2020;8(16):4581–4594. doi:10.1039/D0BM00408A
   PubMed Web of Science ®Google Scholar
• Wang J, Huang J, Zhou W, et al. Hypoxia modulation by dual-drug nanoparticles for enhanced synergistic sonodynamic and starvation therapy. J Nanobiotechnol. 2021;19(1):87. doi:10.1186/s12951-021-00837-0
   PubMed Web of Science ®Google Scholar
• Wen M, Shen J, Wang Z, et al. A cascaded enzyme-loaded Fe-hemoporfin framework for synergistic sonodynamic-starvation therapy of tumors. Nanoscale. 2021;13(11):5910–5920. doi:10.1039/D0NR08508A
   PubMed Web of Science ®Google Scholar
• Wu W, Pu Y, Lin H, Yao H, Shi J. Starvation-sensitized and oxygenation-promoted tumor sonodynamic therapy by a cascade enzymatic approach. Research. 2021;2021:9769867. doi:10.34133/2021/9769867
   PubMedGoogle Scholar
• Bao Y, Chen J, Qiu H, et al. Erythrocyte membrane-camouflaged PCN-224 nanocarriers integrated with platinum nanoparticles and glucose oxidase for enhanced tumor sonodynamic therapy and synergistic starvation therapy. ACS Appl Mater Interfaces. 2021;13(21):24532–24542. doi:10.1021/acsami.1c05644
   PubMed Web of Science ®Google Scholar
• Huang X, Lu Y, Guo M, Du S, Han N. Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view. Theranostics. 2021;11(15):7546–7569. doi:10.7150/thno.56482
   PubMed Web of Science ®Google Scholar
• Oei AL, Vriend LE, Crezee J, Franken NA, Krawczyk PM. Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol. 2015;10:165. doi:10.1186/s13014-015-0462-0
   PubMed Web of Science ®Google Scholar
• Zhu X, Feng W, Chang J, et al. Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperature. Nat Commun. 2016;7:1.
   Web of Science ®Google Scholar
• Wang X, Chen M, Zhou J, Zhang X. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review). Int J Oncol. 2014;45(1):18–30. doi:10.3892/ijo.2014.2399
   PubMed Web of Science ®Google Scholar
• Talaei S, Mellatyar H, Asadi A, Akbarzadeh A, Sheervalilou R, Zarghami N. Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment. Chem Biol Drug Des. 2019;93(5):760–786. doi:10.1111/cbdd.13486
   PubMed Web of Science ®Google Scholar
• Trepel J, Mollapour M, Giaccone G, Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer. 2010;10(8):537–549. doi:10.1038/nrc2887
   PubMed Web of Science ®Google Scholar
• Zhu H, Li Y, Ming Z, Liu W. Glucose oxidase-mediated tumor starvation therapy combined with photothermal therapy for colon cancer. Biomater Sci. 2021;9(16):5577–5587. doi:10.1039/D1BM00869B
   PubMed Web of Science ®Google Scholar
• Shao L, Li Y, Huang F, et al. Complementary autophagy inhibition and glucose metabolism with rattle-structured polydopamine@mesoporous silica nanoparticles for augmented low-temperature photothermal therapy and in vivo photoacoustic imaging. Theranostics. 2020;10(16):7273–7286. doi:10.7150/thno.44668
   PubMed Web of Science ®Google Scholar
• Ren J, Zhang L, Zhang J, et al. Light-activated oxygen self-supplied starving therapy in near-infrared (NIR) window and adjuvant hyperthermia-induced tumor ablation with an augmented sensitivity. Biomaterials. 2020;234:119771. doi:10.1016/j.biomaterials.2020.119771
   PubMed Web of Science ®Google Scholar
• He T, Xu H, Zhang Y, et al. Glucose oxidase-instructed traceable self-oxygenation/hyperthermia dually enhanced cancer starvation therapy. Theranostics. 2020;10(4):1544–1554. doi:10.7150/thno.40439
   PubMed Web of Science ®Google Scholar
• Hu JJ, Liu MD, Gao F, et al. Photo-controlled liquid metal nanoparticle-enzyme for starvation/photothermal therapy of tumor by win-win cooperation. Biomaterials. 2019;217:119303. doi:10.1016/j.biomaterials.2019.119303
   PubMed Web of Science ®Google Scholar
• Li S, Lin K, Hu P, et al. A multifunctional nanoamplifier with self-enhanced acidity and hypoxia relief for combined photothermal/photodynamic/starvation therapy. Int J Pharm. 2021;611:121307. doi:10.1016/j.ijpharm.2021.121307
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang B, Zhang L, et al. Mitochondria-targeted nanospheres with deep tumor penetration for photo/starvation therapy. J Mater Chem B. 2020;8(34):7740–7754. doi:10.1039/D0TB00001A
   PubMed Web of Science ®Google Scholar
• Cao J, Qiao B, Luo Y, et al. A multimodal imaging-guided nanoreactor for cooperative combination of tumor starvation and multiple mechanism-enhanced mild temperature phototherapy. Biomater Sci. 2020;8(23):6561–6578. doi:10.1039/D0BM01350A
   PubMed Web of Science ®Google Scholar
• Zhao L, Yang Q, Guo W, et al. Non-stoichiometric cobalt sulfide nanodots enhance photothermal and chemodynamic therapies against solid tumor. J Colloid Interface Sci. 2021;600:390–402. doi:10.1016/j.jcis.2021.05.058
   PubMed Web of Science ®Google Scholar
• Tian F, Zhong X, Zhao J, et al. Hybrid theranostic microbubbles for ultrasound/photoacoustic imaging guided starvation/low-temperature photothermal/hypoxia-activated synergistic cancer therapy. J Mater Chem B. 2021;9(45):9358–9369. doi:10.1039/D1TB01735G
   PubMed Web of Science ®Google Scholar
• Shubhra QTH, Guo K, Liu Y, Razzak M, Serajum Manir M, Moshiul Alam AKM. Dual targeting smart drug delivery system for multimodal synergistic combination cancer therapy with reduced cardiotoxicity. Acta Biomater. 2021;131:493–507. doi:10.1016/j.actbio.2021.06.016
   PubMed Web of Science ®Google Scholar
• Lu J, Liu F, Li H, Xu Y, Sun S. Width-consistent mesoporous silica nanorods with a precisely controlled aspect ratio for lysosome dysfunctional synergistic chemotherapy/photothermal therapy/starvation therapy/oxidative therapy. ACS Appl Mater Interfaces. 2020;12(22):24611–24622. doi:10.1021/acsami.0c06117
   PubMed Web of Science ®Google Scholar
• Su Y, Zhang X, Lei L, Liu B, Wu S, Shen J. Tumor microenvironment-activatable cyclic cascade reaction to reinforce multimodal combination therapy by destroying the extracellular matrix. ACS Appl Mater Interfaces. 2021;13(11):12960–12971. doi:10.1021/acsami.1c02011
   PubMed Web of Science ®Google Scholar
• Li Z, Rong L. A homotypic membrane-camouflaged biomimetic nanoplatform with gold nanocrystals for synergistic photothermal/starvation/immunotherapy. ACS Appl Mater Interfaces. 2021;13(20):23469–23480. doi:10.1021/acsami.1c04305
   PubMed Web of Science ®Google Scholar
• Cheng X, Hao Z, Chu S, et al. Plasmonic enhanced enzyme activity by catalytic cascade induced mutual benefit tumor starvation/immune/photothermal therapy. Biomater Sci. 2021;9(18):6116–6125. doi:10.1039/D1BM00551K
   PubMed Web of Science ®Google Scholar
• Wang M, Wang D, Chen Q, Li C, Li Z, Lin J. Recent advances in glucose-oxidase-based nanocomposites for tumor therapy. Small. 2019;15(51):e1903895. doi:10.1002/smll.201903895
   PubMed Web of Science ®Google Scholar
• Varghese E, Samuel SM, Líšková A, Samec M, Kubatka P, Büsselberg D. Targeting glucose metabolism to overcome resistance to anticancer chemotherapy in breast cancer. Cancers. 2020;12(8):2252. doi:10.3390/cancers12082252
   PubMed Web of Science ®Google Scholar
• Zhang D, Li J, Wang F, Hu J, Wang S, Sun Y. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett. 2014;355(2):176–183. doi:10.1016/j.canlet.2014.09.003
   PubMed Web of Science ®Google Scholar
• Chen WH, Luo GF, Lei Q, et al. Overcoming the heat endurance of tumor cells by interfering with the anaerobic glycolysis metabolism for improved photothermal therapy. ACS Nano. 2017;11(2):1419–1431. doi:10.1021/acsnano.6b06658
   PubMed Web of Science ®Google Scholar
• Lin YX, Wang Y, Blake S, et al. RNA nanotechnology-mediated cancer immunotherapy. Theranostics. 2020;10(1):281–299. doi:10.7150/thno.35568
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233. doi:10.1016/j.cell.2009.01.002
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001;15(2):188–200. doi:10.1101/gad.862301
   PubMed Web of Science ®Google Scholar
• Dang J, Ye H, Li Y, Liang Q, Li X, Yin L. Multivalency-assisted membrane-penetrating siRNA delivery sensitizes photothermal ablation via inhibition of tumor glycolysis metabolism. Biomaterials. 2019;223:119463. doi:10.1016/j.biomaterials.2019.119463
   PubMed Web of Science ®Google Scholar
• Jin D, Zhang J, Huang Y, et al. Recent advances in the development of metal-organic framework-based gas-releasing nanoplatforms for synergistic cancer therapy. Dalton Trans. 2021;50(4):1189–1196. doi:10.1039/D0DT03767B
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang S, Chen Z, et al. Nitric oxide release activated near-infrared photothermal agent for synergistic tumor treatment. Biomaterials. 2021;276:121017. doi:10.1016/j.biomaterials.2021.121017
   PubMed Web of Science ®Google Scholar
• Zhu D, Liu Z, Li Y, Huang Q, Xia L, Li K. Delivery of manganese carbonyl to the tumor microenvironment using tumor-derived exosomes for cancer gas therapy and low dose radiotherapy. Biomaterials. 2021;274:120894. doi:10.1016/j.biomaterials.2021.120894
   PubMed Web of Science ®Google Scholar
• Wang M, Hou Z, Liu S, et al. A multifunctional nanovaccine based on l-arginine-loaded black mesoporous titania: ultrasound-triggered synergistic cancer sonodynamic therapy/gas therapy/immunotherapy with remarkably enhanced efficacy. Small. 2021;17(6):e2005728–e2005728. doi:10.1002/smll.202005728
   PubMed Web of Science ®Google Scholar
• Liu B, Liang S, Wang Z, et al. A Tumor-Microenvironment-Responsive Nanocomposite for Hydrogen Sulfide Gas and Trimodal-Enhanced Enzyme Dynamic Therapy. Adv Mater. 2021;33:2101223.
   Web of Science ®Google Scholar
• Yue L, Yang K, Li J, Cheng Q, Wang R. Self-propelled asymmetrical nanomotor for self-reported gas therapy. Small. 2021;17(34):e2102286–e2102286. doi:10.1002/smll.202102286
   PubMed Web of Science ®Google Scholar
• Xiang HJ, Deng Q, An L, Guo M, Yang SP, Liu JG. Tumor cell specific and lysosome-targeted delivery of nitric oxide for enhanced photodynamic therapy triggered by 808 nm near-infrared light. Chem Commun. 2016;52(1):148–151. doi:10.1039/C5CC07006F
   PubMed Web of Science ®Google Scholar
• Kim J, Yung BC, Kim WJ, Chen X. Combination of nitric oxide and drug delivery systems: tools for overcoming drug resistance in chemotherapy. J Control Release. 2017;263:223–230. doi:10.1016/j.jconrel.2016.12.026
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Z-H, Pan P, Zeng R-Y, Zhang X-Z. Tumor-specific ONOO- nanogenerator for improved drug delivery and enhanced chemotherapy of tumor. ACS Nano. 2021;15:11514–11525.
   PubMed Web of Science ®Google Scholar
• Zhai M, Gong P, Li H, et al. Metastable interface biomimetic synthesis of a smart nanosystem for enhanced starvation/gas therapy. J Colloid Interface Sci. 2021;599:149–157. doi:10.1016/j.jcis.2021.04.042
   PubMed Web of Science ®Google Scholar
• Peng J, Gong P, Song S, et al. Biomineralized synthesis of a smart O(2)-regenerating nanoreactor for highly efficient starvation/gas therapy. Mater Sci Eng C Mater Biol Appl. 2021;126:112132. doi:10.1016/j.msec.2021.112132
   PubMed Web of Science ®Google Scholar
• Fan W, Lu N, Huang P, et al. Glucose-responsive sequential generation of hydrogen peroxide and nitric oxide for synergistic cancer starving-like/gas therapy. Angew Chem Int Ed Engl. 2017;56(5):1229–1233. doi:10.1002/anie.201610682
   PubMed Web of Science ®Google Scholar
• Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov. 2010;9(9):728–743. doi:10.1038/nrd3228
   PubMed Web of Science ®Google Scholar
• Wu J, Meng Z, Exner AA, et al. Biodegradable cascade nanocatalysts enable tumor-microenvironment remodeling for controllable CO release and targeted/synergistic cancer nanotherapy. Biomaterials. 2021;276:121001. doi:10.1016/j.biomaterials.2021.121001
   PubMed Web of Science ®Google Scholar
• Guan Q, Zhou LL, Li YA, Dong YB. A nanoscale metal-organic framework for combined photodynamic and starvation therapy in treating breast tumors. Chem Commun. 2019;55(99):14898–14901. doi:10.1039/C9CC07510K
   PubMed Web of Science ®Google Scholar
• Soenen SJ, Parak WJ, Rejman J, Manshian B. (Intra)cellular stability of inorganic nanoparticles: effects on cytotoxicity, particle functionality, and biomedical applications. Chem Rev. 2015;115(5):2109–2135. doi:10.1021/cr400714j
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Han JW, Eppakayala V, Jeyaraj M, Kim JH. Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells. Biomed Res Int. 2013;2013:535796. doi:10.1155/2013/535796
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li Y, Gao Z, et al. Mesoporous silica-coated silver nanoframes as drug-delivery vehicles for chemo/starvation/metal ion multimodality therapy. Langmuir. 2020;36(23):6345–6351. doi:10.1021/acs.langmuir.0c00191
   PubMed Web of Science ®Google Scholar
• Zhang YF, Yang YC, Jiang SS, et al. Degradable silver-based nanoplatform for synergistic cancer starving-like/metal ion therapy. Mater Horizons. 2019;6(1):169–175. doi:10.1039/C8MH00908B
   Web of Science ®Google Scholar
• Sun D, Qi G, Ma K, et al. Tumor microenvironment-activated degradable multifunctional nanoreactor for synergistic cancer therapy and glucose SERS feedback. iScience. 2020;23(7):101274. doi:10.1016/j.isci.2020.101274
   PubMed Web of Science ®Google Scholar
• Wu S, Zhang K, Liang Y, et al. Nano-enabled tumor systematic energy exhaustion via zinc (II) interference mediated glycolysis inhibition and specific GLUT1 depletion. Adv Sci. 2021;9(7):e2103534. doi:10.1002/advs.202103534
   Web of Science ®Google Scholar
• Yue L, Sun T, Yang K, et al. Supramolecular nanovesicles for synergistic glucose starvation and hypoxia-activated gene therapy of cancer. Nanoscale. 2021;13(21):9570–9576. doi:10.1039/D1NR02159A
   PubMed Web of Science ®Google Scholar
• Lu Z, Gao J, Fang C, Zhou Y, Li X, Han G. Porous Pt nanospheres incorporated with GOx to enable synergistic oxygen-inductive starvation/electrodynamic tumor therapy. Adv Sci. 2020;7(17):2001223. doi:10.1002/advs.202001223
   Web of Science ®Google Scholar
• Li J, Eu JQ, Kong LR, et al. Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapy. Molecules. 2020;25(20):4831. doi:10.3390/molecules25204831
   PubMed Web of Science ®Google Scholar
• Liu Y, He C, Huang X. Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism. Oncotarget. 2017;8(43):75206–75216. doi:10.18632/oncotarget.20663
   PubMedGoogle Scholar
• Sun H, Zhu A, Zhou X, Wang F. Suppression of pyruvate dehydrogenase kinase-2 re-sensitizes paclitaxel-resistant human lung cancer cells to paclitaxel. Oncotarget. 2017;8(32):52642–52650. doi:10.18632/oncotarget.16991
   PubMedGoogle Scholar
• Shin YK, Yoo BC, Hong YS, et al. Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance. Electrophoresis. 2009;30(12):2182–2192. doi:10.1002/elps.200800806
   PubMed Web of Science ®Google Scholar
• Palsson-McDermott EM, Dyck L, Zasłona Z, et al. Pyruvate kinase M2 is required for the expression of the immune checkpoint PD-L1 in immune cells and tumors. Front Immunol. 2017;8:1300. doi:10.3389/fimmu.2017.01300
   PubMed Web of Science ®Google Scholar
• Liu WR, Tian MX, Yang LX, et al. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma. Oncotarget. 2015;6(2):846–861. doi:10.18632/oncotarget.2749
   PubMedGoogle Scholar
• Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer - where do we stand? Mol Metab. 2020;33:102–121. doi:10.1016/j.molmet.2019.06.026
   PubMed Web of Science ®Google Scholar
• Raez LE, Papadopoulos K, Ricart AD, et al. A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2013;71(2):523–530. doi:10.1007/s00280-012-2045-1
   PubMed Web of Science ®Google Scholar
• Lien EC, Westermark AM, Zhang Y, et al. Low glycaemic diets alter lipid metabolism to influence tumour growth. Nature. 2021;599(7884):302–307. doi:10.1038/s41586-021-04049-2
   PubMed Web of Science ®Google Scholar
• Cheon DJ, Orsulic S. Mouse models of cancer. Annu Rev Pathol. 2011;6(1):95–119. doi:10.1146/annurev.pathol.3.121806.154244
   PubMed Web of Science ®Google Scholar
• Jing X, Yang F, Shao C, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157. doi:10.1186/s12943-019-1089-9
   PubMed Web of Science ®Google Scholar
• Lee JD, Cai Q, Shu XO, Nechuta SJ. The role of biomarkers of oxidative stress in breast cancer risk and prognosis: a systematic review of the epidemiologic literature. J Women's Health. 2017;26(5):467–482. doi:10.1089/jwh.2016.5973
   PubMed Web of Science ®Google Scholar
• Tsun Z-Y, Possemato R. Amino acid management in cancer. Semin Cell Dev Biol. 2015;43:22–32. doi:10.1016/j.semcdb.2015.08.002
   PubMed Web of Science ®Google Scholar
• Cheng C, Geng F, Cheng X, Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun. 2018;38(1):27. doi:10.1186/s40880-018-0301-4
   Web of Science ®Google Scholar
• Chen QW, Wang JW, Wang XN, et al. Inhibition of tumor progression through the coupling of bacterial respiration with tumor metabolism. Angew Chem Int Ed Engl. 2020;59(48):21562–21570. doi:10.1002/anie.202002649
   PubMed Web of Science ®Google Scholar
• Kou L, Jiang X, Tang Y, et al. Resetting amino acid metabolism of cancer cells by ATB(0,+)-targeted nanoparticles for enhanced anticancer therapy. Bioact Mater. 2022;9:15–28. doi:10.1016/j.bioactmat.2021.07.009
   PubMed Web of Science ®Google Scholar
• Cao S, Saw PE, Shen Q, Li R, Liu Y, Xu X. Reduction-responsive RNAi nanoplatform to reprogram tumor lipid metabolism and repolarize macrophage for combination pancreatic cancer therapy. Biomaterials. 2021;280:121264. doi:10.1016/j.biomaterials.2021.121264
   PubMed Web of Science ®Google Scholar
• De Bock K, Georgiadou M, Schoors S, et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell. 2013;154(3):651–663. doi:10.1016/j.cell.2013.06.037
   PubMed Web of Science ®Google Scholar
• Martínez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21(10):669–680. doi:10.1038/s41568-021-00378-6
   PubMed Web of Science ®Google Scholar
• Fu LH, Li C, Yin W, et al. A versatile calcium phosphate nanogenerator for tumor microenvironment-activated cancer synergistic therapy. Adv Healthc Mater. 2021;10(23):e2101563. doi:10.1002/adhm.202101563
   PubMed Web of Science ®Google Scholar
• Zhang YH, Qiu WX, Zhang M, Zhang L, Zhang XZ. MnO(2) motor: a prospective cancer-starving therapy promoter. ACS Appl Mater Interfaces. 2018;10(17):15030–15039. doi:10.1021/acsami.8b01818
   PubMed Web of Science ®Google Scholar
• Wen H, Fei Y, Cai R, et al. Tumor-activatable biomineralized nanotherapeutics for integrative glucose starvation and sensitized metformin therapy. Biomaterials. 2021;278:121165. doi:10.1016/j.biomaterials.2021.121165
   PubMed Web of Science ®Google Scholar
• Liu X, Liu J, Chen S, et al. Dual-path modulation of hydrogen peroxide to ameliorate hypoxia for enhancing photodynamic/starvation synergistic therapy. J Mater Chem B. 2020;8(43):9933–9942. doi:10.1039/D0TB01556C
   PubMed Web of Science ®Google Scholar
• Liu B, Wang Z, Li T, et al. Rapid decomposition and catalytic cascade nanoplatforms based on enzymes and Mn-etched dendritic mesoporous silicon for MRI-guided synergistic therapy. ACS Appl Mater Interfaces. 2020;12(41):45772–45788. doi:10.1021/acsami.0c12580
   PubMed Web of Science ®Google Scholar
• Zhu Y, Shi H, Li T, et al. A dual functional nanoreactor for synergistic starvation and photodynamic therapy. ACS Appl Mater Interfaces. 2020;12(16):18309–18318. doi:10.1021/acsami.0c01039
   PubMed Web of Science ®Google Scholar
• Ranji-Burachaloo H, Reyhani A, Gurr PA, Dunstan DE, Qiao GG. Combined Fenton and starvation therapies using hemoglobin and glucose oxidase. Nanoscale. 2019;11(12):5705–5716. doi:10.1039/C8NR09107B
   PubMed Web of Science ®Google Scholar
• Yao Z, Zhang B, Liang T, Ding J, Min Q, Zhu JJ. Promoting oxidative stress in cancer starvation therapy by site-specific startup of hyaluronic acid-enveloped dual-catalytic nanoreactors. ACS Appl Mater Interfaces. 2019;11(21):18995–19005. doi:10.1021/acsami.9b06034
   PubMed Web of Science ®Google Scholar
• Ming J, Zhu T, Yang W, et al. Pd@Pt-GOx/HA as a novel enzymatic cascade nanoreactor for high-efficiency starving-enhanced chemodynamic cancer therapy. ACS Appl Mater Interfaces. 2020;12(46):51249–51262. doi:10.1021/acsami.0c15211
   PubMed Web of Science ®Google Scholar
• Wang Y, Song M. pH-responsive cascaded nanocatalyst for synergistic like-starvation and chemodynamic therapy. Colloids Surf B Biointerfaces. 2020;192:111029. doi:10.1016/j.colsurfb.2020.111029
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu B, Sun Q, et al. Fusiform-like copper(II)-based metal-organic framework through relief hypoxia and GSH-depletion co-enhanced starvation and chemodynamic synergetic cancer therapy. ACS Appl Mater Interfaces. 2020;12(15):17254–17267. doi:10.1021/acsami.0c01539
   PubMed Web of Science ®Google Scholar
• Hu Y, Wang K, Ye C. “Four-in-one” nanozyme and natural enzyme symbiotic system of Cu2-xSe-GOx for cervical cancer therapy. Chemistry. 2021;28:e202102885.
   PubMed Web of Science ®Google Scholar
• Kou Y, Dai Z, Cui P, et al. A flowerlike FePt/MnO(2)/GOx-based cascade nanoreactor with sustainable O(2) supply for synergistic starvation-chemodynamic anticancer therapy. J Mater Chem B. 2021;9(40):8480–8490. doi:10.1039/D1TB01539G
   PubMed Web of Science ®Google Scholar
• Meng X, Zhang F, Guo H, et al. One-pot approach to Fe(2+) /Fe(3+) -based MOFs with enhanced catalytic activity for Fenton reaction. Adv Healthc Mater. 2021;10(19):e2100780. doi:10.1002/adhm.202100780
   PubMed Web of Science ®Google Scholar
• Zhou J, Li M, Hou Y, et al. Engineering of a nanosized biocatalyst for combined tumor starvation and low-temperature photothermal therapy. ACS Nano. 2018;12(3):2858–2872. doi:10.1021/acsnano.8b00309
   PubMed Web of Science ®Google Scholar
• Gao P, Shi M, Wei R, et al. A biomimetic MOF nanoreactor enables synergistic suppression of intracellular defense systems for augmented tumor ablation. Chem Commun. 2020;56(6):924–927. doi:10.1039/C9CC08498C
   PubMed Web of Science ®Google Scholar
• Zhang MK, Li CX, Wang SB, et al. Tumor starvation induced spatiotemporal control over chemotherapy for synergistic therapy. Small. 2018;14(50):e1803602. doi:10.1002/smll.201803602
   PubMed Web of Science ®Google Scholar
• Hang L, Zhang T, Wen H, et al. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression. Theranostics. 2021;11(20):10001–10011. doi:10.7150/thno.65399
   PubMed Web of Science ®Google Scholar
• Du X, Zhang T, Ma G, Gu X, Wang G, Li J. Glucose-responsive mesoporous silica nanoparticles to generation of hydrogen peroxide for synergistic cancer starvation and chemistry therapy. Int J Nanomedicine. 2019;14:2233–2251. doi:10.2147/IJN.S195900
   PubMed Web of Science ®Google Scholar
• Song S, Peng J, Wu Y, et al. Biomimetic synthesis of a novel O(2)-regeneration nanosystem for enhanced starvation/chemo-therapy. Nanotechnology. 2021;33(2):025102.
   Web of Science ®Google Scholar
• Wang Y, Liu Z, Wang H, et al. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory. Acta Biomater. 2019;92:241–253. doi:10.1016/j.actbio.2019.05.009
   PubMed Web of Science ®Google Scholar
• Yu J, He X, Wang Z, et al. Combination of starvation therapy and Pt-NP based chemotherapy for synergistic cancer treatment. J Mater Chem B. 2021;9(32):6406–6411. doi:10.1039/D1TB01222C
   PubMed Web of Science ®Google Scholar
• Gao W, Wei S, Li Z, et al. Nano magnetic liposomes-encapsulated parthenolide and glucose oxidase for ultra-efficient synergistic antitumor therapy. Nanotechnology. 2020;31(35):355104. doi:10.1088/1361-6528/ab92c8
   PubMed Web of Science ®Google Scholar
• Wu F, Zhang Q, Zhang M, et al. Hollow porous carbon coated FeS(2)-based nanocatalysts for multimodal imaging-guided photothermal, starvation, and triple-enhanced chemodynamic therapy of cancer. ACS Appl Mater Interfaces. 2020;12(9):10142–10155. doi:10.1021/acsami.0c00170
   PubMed Web of Science ®Google Scholar
• Xu K, Wu X, Cheng Y, et al. A biomimetic nanoenzyme for starvation therapy enhanced photothermal and chemodynamic tumor therapy. Nanoscale. 2020;12(45):23159–23165. doi:10.1039/D0NR05097K
   PubMed Web of Science ®Google Scholar
• Gu D, Liu Z, Wu H, et al. Dual catalytic cascaded nanoplatform for photo/chemodynamic/starvation synergistic therapy. Colloids Surf B Biointerfaces. 2021;199:111538. doi:10.1016/j.colsurfb.2020.111538
   PubMed Web of Science ®Google Scholar
• Zhao Y, Kong W, Wang P, et al. Tumor-specific multipath nucleic acid damages strategy by symbiosed Nanozyme@Enzyme with synergistic self-cyclic catalysis. Small. 2021;17(28):e2100766. doi:10.1002/smll.202100766
   PubMed Web of Science ®Google Scholar
• Wang Q, Niu D, Shi J, Wang L. A three-in-one ZIFs-derived CuCo(O)/GOx@PCNs hybrid cascade nanozyme for immunotherapy/enhanced starvation/photothermal therapy. ACS Appl Mater Interfaces. 2021;13(10):11683–11695. doi:10.1021/acsami.1c01006
   PubMed Web of Science ®Google Scholar